RE:Looking back at 2020 outlook by John D. VandermostenI am not sure whether he still covers PMN, he pretty much tweets about every other company and has been quite about since October last year. Anyways we did put our money way before these Boston guys and fda green flag , so I do really hope we get somewhere soon . And now the plus side is we have serology too . Cheers to all of us who didn't cash out at uncertain times